Edwards Lifesciences Pre-Tax Profit Margin 2010-2024 | EW

Current and historical pre-tax profit margin for Edwards Lifesciences (EW) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Edwards Lifesciences pre-tax profit margin for the three months ending March 31, 2024 was .
Edwards Lifesciences Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-03-31 $6.14B $1.61B 26.19%
2023-12-31 $6.01B $1.60B 26.63%
2023-09-30 $5.82B $1.64B 28.11%
2023-06-30 $5.66B $1.60B 28.35%
2023-03-31 $5.50B $1.73B 31.45%
2022-12-31 $5.38B $1.77B 32.83%
2022-09-30 $5.36B $1.68B 31.39%
2022-06-30 $5.36B $1.67B 31.15%
2022-03-31 $5.36B $1.75B 32.65%
2021-12-31 $5.23B $1.70B 32.52%
2021-09-30 $5.10B $1.68B 33.01%
2021-06-30 $4.93B $1.66B 33.60%
2021-03-31 $4.48B $0.94B 21.03%
2020-12-31 $4.39B $0.92B 20.90%
2020-09-30 $4.37B $0.88B 20.07%
2020-06-30 $4.32B $0.82B 18.86%
2020-03-31 $4.48B $1.25B 27.97%
2019-12-31 $4.35B $1.17B 26.84%
2019-09-30 $4.15B $0.85B 20.45%
2019-06-30 $3.97B $0.80B 20.08%
2019-03-31 $3.82B $0.78B 20.30%
2018-12-31 $3.72B $0.76B 20.46%
2018-09-30 $3.64B $1.09B 29.93%
2018-06-30 $3.55B $1.05B 29.61%
2018-03-31 $3.45B $1.01B 29.18%
2017-12-31 $3.44B $1.04B 30.14%
2017-09-30 $3.32B $0.91B 27.50%
2017-06-30 $3.23B $0.89B 27.37%
2017-03-31 $3.15B $0.85B 26.92%
2016-12-31 $2.96B $0.74B 24.87%
2016-09-30 $2.87B $0.70B 24.56%
2016-06-30 $2.74B $0.67B 24.43%
2016-03-31 $2.60B $0.64B 24.72%
2015-12-31 $2.49B $0.62B 24.98%
2015-09-30 $2.44B $0.59B 24.13%
2015-06-30 $2.43B $0.56B 22.99%
2015-03-31 $2.39B $1.23B 51.46%
2014-12-31 $2.32B $1.14B 49.27%
2014-09-30 $2.24B $1.11B 49.60%
2014-06-30 $2.13B $1.09B 51.20%
2014-03-31 $2.07B $0.40B 19.22%
2013-12-31 $2.05B $0.51B 25.02%
2013-09-30 $2.02B $0.53B 26.29%
2013-06-30 $1.97B $0.52B 26.57%
2013-03-31 $1.94B $0.49B 25.45%
2012-12-31 $1.90B $0.39B 20.43%
2012-09-30 $1.82B $0.34B 18.58%
2012-06-30 $1.78B $0.30B 16.98%
2012-03-31 $1.73B $0.29B 16.50%
2011-12-31 $1.68B $0.29B 16.97%
2011-09-30 $1.64B $0.29B 17.43%
2011-06-30 $1.58B $0.29B 18.64%
2011-03-31 $1.51B $0.29B 18.99%
2010-12-31 $1.45B $0.27B 18.52%
2010-09-30 $1.40B $0.26B 18.54%
2010-06-30 $1.38B $0.29B 20.88%
2010-03-31 $1.35B $0.29B 21.11%
2009-12-31 $1.32B $0.30B 22.98%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $52.125B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $203.970B 24.72
Intuitive Surgical (ISRG) United States $161.392B 91.55
DexCom (DXCM) United States $44.405B 67.27
Alcon (ALC) Switzerland $44.397B 31.81
IQVIA Holdings (IQV) United States $40.917B 23.74
IDEXX Laboratories (IDXX) United States $38.667B 45.32
STERIS (STE) Ireland $22.172B 25.90
Hologic (HOLX) United States $18.229B 20.39
Waters (WAT) United States $17.957B 26.39
SONOVA HOLDING (SONVY) Switzerland $17.634B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $11.555B 13.49
Teleflex (TFX) United States $10.447B 16.26
Sysmex ADR (SSMXY) Japan $10.171B 31.89
Globus Medical (GMED) United States $9.832B 28.82
Penumbra (PEN) United States $7.360B 83.64
Glaukos (GKOS) United States $6.081B 0.00
Masimo (MASI) United States $5.678B 32.65
TransMedics (TMDX) United States $4.848B 460.00
Integer Holdings (ITGR) United States $4.225B 25.53
PROCEPT BioRobotics (PRCT) United States $3.470B 0.00
Inari Medical (NARI) United States $3.192B 0.00
LivaNova (LIVN) United Kingdom $2.865B 17.01
Tandem Diabetes Care (TNDM) United States $2.820B 0.00
Integra LifeSciences Holdings (IART) United States $2.470B 10.77
Veracyte (VCYT) United States $1.772B 0.00
RxSight (RXST) United States $1.730B 0.00
Alphatec Holdings (ATEC) United States $1.551B 0.00
Artivion (AORT) United States $1.135B 108.88
Silk Road Medical (SILK) United States $1.068B 0.00
OPKO Health (OPK) United States $1.039B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.009B 19.63
Pulse Biosciences (PLSE) United States $0.977B 0.00
OrthoPediatrics (KIDS) United States $0.776B 0.00
SiBone (SIBN) United States $0.684B 0.00
Paragon 28 (FNA) United States $0.672B 0.00
Mesa Laboratories (MLAB) United States $0.585B 17.30
ORTHOFIX MEDICAL INC (OFIX) United States $0.580B 0.00
IRadimed (IRMD) United States $0.572B 32.06
Treace Medical Concepts (TMCI) United States $0.489B 0.00
Pacific Biosciences Of California (PACB) United States $0.452B 0.00
AxoGen (AXGN) United States $0.399B 0.00
Sight Sciences (SGHT) United States $0.379B 0.00
Nevro (NVRO) United States $0.334B 0.00
Tactile Systems Technology (TCMD) United States $0.294B 10.07
AngioDynamics (ANGO) United States $0.288B 0.00
Semler Scientific (SMLR) United States $0.237B 12.02
NeuroPace (NPCE) United States $0.229B 0.00
Delcath Systems (DCTH) United States $0.229B 0.00
Inogen (INGN) United States $0.218B 0.00
CVRx (CVRX) United States $0.202B 0.00
ClearPoint Neuro (CLPT) United States $0.194B 0.00
EDAP TMS S.A (EDAP) France $0.189B 0.00
908 Devices (MASS) United States $0.186B 0.00
Accuray (ARAY) United States $0.179B 0.00
Atossa Genetics (ATOS) United States $0.169B 0.00
Alpha Tau Medical (DRTS) Israel $0.146B 0.00
KORU Medical Systems (KRMD) United States $0.115B 0.00
Sensus Healthcare (SRTS) United States $0.098B 20.69
Spectral Diagnostics (EDTXF) Canada $0.098B 0.00
Hyperfine (HYPR) United States $0.087B 0.00
EnVVeno Medical (NVNO) United States $0.075B 0.00
Monogram Orthopaedics (MGRM) United States $0.069B 0.00
InspireMD (NSPR) Israel $0.059B 0.00
Neuronetics (STIM) United States $0.058B 0.00
LENSAR (LNSR) United States $0.056B 0.00
Vicarious Surgical (RBOT) United States $0.046B 0.00
Lucid Diagnostics (LUCD) United States $0.045B 0.00
T2 Biosystems (TTOO) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.044B 0.00
Precision Optics (POCI) United States $0.036B 0.00
DarioHealth (DRIO) United States $0.036B 0.00
ReWalk Robotics (LFWD) Israel $0.033B 0.00
Spectral AI (MDAI) United States $0.030B 0.00
Rapid Micro Biosystems (RPID) United States $0.030B 0.00
Autonomix Medical (AMIX) United States $0.027B 0.00
Accelerate Diagnostics (AXDX) United States $0.025B 0.00
Pixie Dust Technologies (PXDT) Japan $0.022B 0.00
Ekso Bionics Holdings (EKSO) United States $0.022B 0.00
Aspira Women's Health (AWH) United States $0.021B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
NexGel (NXGL) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.012B 0.00
PAVmed (PAVM) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00